These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8781463)

  • 41. Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.
    Ueno SI; Hatano T; Okuzumi A; Saiki S; Oji Y; Mori A; Koinuma T; Fujimaki M; Takeshige-Amano H; Kondo A; Yoshikawa N; Nojiri T; Kurano M; Yasukawa K; Yatomi Y; Ikeda H; Hattori N
    Ann Clin Transl Neurol; 2020 Mar; 7(3):307-317. PubMed ID: 32059082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.
    Wheeler JG; Juzwishin KD; Eiriksdottir G; Gudnason V; Danesh J
    PLoS Med; 2005 Mar; 2(3):e76. PubMed ID: 15783260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes.
    Xia X; Zhao C; Peng FF; Luo QM; Zhou Q; Lin ZC; Yu XQ; Huang FX
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):20-6. PubMed ID: 26712272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between serum uric acid and motor subtypes of Parkinson's disease.
    Lolekha P; Wongwan P; Kulkantrakorn K
    J Clin Neurosci; 2015 Aug; 22(8):1264-7. PubMed ID: 26055955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum uric acid level and the incidence of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study.
    Lee JK; Ryoo JH; Choi JM; Park SK
    J Prev Med Public Health; 2014 Nov; 47(6):317-26. PubMed ID: 25475199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study.
    Yiu A; Van Hemelrijck M; Garmo H; Holmberg L; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
    Oncotarget; 2017 Jun; 8(26):42332-42342. PubMed ID: 28418841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re: "plasma urate and risk of Parkinson's disease".
    Wise BL; Neogi T; Zhang Y
    Am J Epidemiol; 2008 Mar; 167(6):752-3; author reply 753-4. PubMed ID: 18283033
    [No Abstract]   [Full Text] [Related]  

  • 48. Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.
    Kamei K; Konta T; Hirayama A; Ichikawa K; Kubota I; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Narita I; Kondo M; Shibagaki Y; Kasahara M; Asahi K; Watanabe T
    Clin Exp Nephrol; 2017 Jun; 21(3):497-503. PubMed ID: 27405620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program.
    Goldberg RJ; Burchfiel CM; Benfante R; Chiu D; Reed DM; Yano K
    Arch Intern Med; 1995 Apr; 155(7):686-94. PubMed ID: 7695456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?
    Moccia M; Picillo M; Erro R; Vitale C; Longo K; Amboni M; Santangelo G; Spina E; De Rosa A; De Michele G; Santoro L; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2014 Jul; 20(7):772-5. PubMed ID: 24725754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.
    Solomon DH; Glynn RJ; MacFadyen JG; Libby P; Thuren T; Everett BM; Ridker PM
    Ann Intern Med; 2018 Oct; 169(8):535-542. PubMed ID: 30242335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease.
    Vieru E; Köksal A; Mutluay B; Dirican AC; Altunkaynak Y; Baybas S
    Neurol Sci; 2016 May; 37(5):743-7. PubMed ID: 26753800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men.
    Strasak AM; Lang S; Kneib T; Brant LJ; Klenk J; Hilbe W; Oberaigner W; Ruttmann E; Kaltenbach L; Concin H; Diem G; Pfeiffer KP; Ulmer H;
    Ann Epidemiol; 2009 Jan; 19(1):15-24. PubMed ID: 18835524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.
    Picillo M; Santangelo G; Moccia M; Erro R; Amboni M; Prestipino E; Longo K; Vitale C; Spina E; Orefice G; Barone P; Pellecchia MT
    J Neural Transm (Vienna); 2016 Apr; 123(4):371-7. PubMed ID: 26739446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uric acid in Parkinson's disease.
    Schlesinger I; Schlesinger N
    Mov Disord; 2008 Sep; 23(12):1653-7. PubMed ID: 18618666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum uric acid levels and risk of kidney cancer incidence and mortality: A prospective cohort study.
    Dai XY; He QS; Jing Z; Yuan JQ
    Cancer Med; 2020 Aug; 9(15):5655-5661. PubMed ID: 32537937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Mar; 17(2):250-7. PubMed ID: 11921109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum Uric Acid Concentrations Can Predict Hypertension: A Longitudinal Population-Based Epidemiological Study.
    Zheng R; Yang T; Chen Q; Chen C; Mao Y
    Horm Metab Res; 2017 Nov; 49(11):873-879. PubMed ID: 28922678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum cholesterol levels and the risk of Parkinson's disease.
    de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
    Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.